Introduction
In January 2025, the prestigious journal Nutrients published an original study by researchers from Democritus University of Thrace and QLC on the benefits of a new probiotic strain, Lactiplantibacillus pentosus PE11, in healthy laboratory animals. This research paves the way for a deeper understanding of how probiotics support our day-to-day health.
Objective and Methods
The investigators examined the effects of PE11 in healthy mice over a six-week period. Throughout this protocol, mice receiving a daily dose of L. pentosus PE11 were closely monitored for their overall health status. Concurrently, blood biochemical analyses were performed to assess liver-function markers and lipid profiles, and fecal samples were collected for comprehensive microbiome mapping. Finally, gene expression in the cecum was analyzed with a focus on the inflammation marker Tnf and the tight-junction protein Zo1, which is critical for intestinal barrier integrity.
Key Findings
1. Microbiome Restructuring:
• There was an increase in the Firmicutes/Bacteroidetes ratio, indicating a more “host-friendly” gut environment.
• The relative abundance of the Lachnospiraceae, Ruminococcaceae, and Rikenellaceae families rose—groups known for short-chain fatty acid production and maintaining epithelial health.
2. Reduced Inflammatory Signaling & Improved Barrier Integrity:
• Expression of the Tnf gene (producer of TNF-α) decreased.
• Expression of Zo1, a key protein marker for the tight junctions between intestinal cells, increased.
3. Lipid Metabolism Improvements:
• Triglyceride levels and ALT (alanine aminotransferase) dropped significantly within physiological norms, with a trend toward reduced total cholesterol as well.
Conclusions and Outlook
Administration of L. pentosus PE11 in healthy mice appears to promote the growth of “beneficial” bacterial groups in the gut, exert anti-inflammatory effects, and enhance intestinal barrier integrity. It also supports lipid regulation, contributing to a healthier metabolic profile. These findings suggest that PE11 holds significant potential not only for therapeutic use but also as a dietary supplement to maintain and improve overall health. Future clinical trials in humans will determine the optimal mode of delivery and dosing to fully harness the promise of this probiotic strain.
You can read the full article here.